Woodline Partners »

Udr shares owned by Woodline Partners

Quarter-by-quarter ownership of Udr (UDR) shares owned by Woodline Partners from 13F filings

Historical chart of Woodline Partners investment in Udr

Tip: Access up to 7 years of quarterly data

All positions including Udr held by Woodline Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Udr by Woodline Partners

Quarter filed Position value Share count Share price at filing
2024-09-30 $22M 483k 45.34

More positions owned by Woodline Partners

Meta Platforms Cl A (META)
Gilead Sciences (GILD)
Abbvie (ABBV)
Revolution Medicines (RVMD)
Vaxcyte (PCVX)
Asml Holding N V N Y Registry Shs (ASML)
Nuvalent Inc-a (NUVL)
Permian Resources Corp Class A Com (PR)
Encana Corporation (OVV)
Keysight Technologies (KEYS)
Danaher Corporation (DHR)
Aon Shs Cl A (AON)
Stmicroelectronics N V Ny Registry (STM)
Regeneron Pharmaceuticals (REGN)
EQT Corporation (EQT)

View all positions for Woodline Partners

Top funds holding Udr

Vanguard Group
BlackRock
BlackRock
Cohen & Steers Capital Management
State Street Corporation
Centersquare Investment Management
Capital Research Global Investors
Jpmorgan Chase & Co
Geode Capital Management
Daiwa Securities Group
Dimensional Fund Advisors
Charles Schwab Investment Management
Invesco
PGGM Vermogensbeheer B.V.
Northern Trust

View all funds holding Udr